相关实验视频

Updated: Jun 9, 2025

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

来自Lnc-H19的蛋白质塑造了质母细胞瘤的免疫抑制微环境

Junju Chen¹, Yixin Gao¹, Jian Zhong¹

¹Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Guangdong Provincial Key Laboratory of Brain Function and Disease, Guangzhou, Guangdong 510080, China.

Cell reports. Medicine

|October 31, 2024

概括

一种新型蛋白质H19-IRP通过招募髓状细胞衍生抑制细胞和巨细胞来驱动质母细胞瘤 (GBM) 的免疫抑制. 用疫苗准H19-IRP显示出治疗这种致命的大脑癌症的希望.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

质母细胞瘤 (GBM) 呈现出一种免疫抑制性瘤微环境 (TME),阻碍免疫疗法的有效性.
驱动GBM-TME的机制仍然不完全理解.
长非编码RNA (LncRNA) H19已知作用,但其蛋白质编码潜力正在研究中.

研究的目的:

阐明免疫抑制药物GBM-TME的机制.
为了确定质母细胞瘤的新型治疗点.
评估针对GBM免疫疗法的H19-IRP向的潜力.

主要方法:

研究了H19编码蛋白H19-IRP在GBM中的功能.
分析了H19-IRP与CCL2和galactin-9促进剂的结合.
评估H19-IRP作为MHC-I.呈现的瘤相关抗原 (TAA).
在GBM模型中开发并测试了针对H19-IRP的循环RNA疫苗 (circH19-vac).

主要成果:

与H19RNA不同的是,H19-IRP通过激活CCL2和galactin-9转录来促进GBM免疫抑制.
H19-IRP招募髓质衍生抑制细胞 (MDSC) 和瘤相关巨细胞 (TAM),诱导T细胞耗尽.
在临床GBM中,H19-IRP过度表达,并由MHC-I呈现,作为TAA.
该circH19-vac诱导了细胞毒性T细胞反应,并抑制了GBM的生长.

结论:

通过招募MDSC和TAM,H19-IRP在建立免疫抑制性GBM-TME方面发挥着关键作用.
H19-IRP代表了一种有前途的瘤相关抗原,用于开发新的GBM免疫疗法.
用癌症疫苗准H19-IRP为质母细胞瘤提供了一个潜在的治疗策略.

关键词:

在GBMGBMGBMGBMGBM H19 H19 是一种H19病毒.H19-IRPP是什么意思 H19-IRP是什么意思这是一个LncRNARNA.在TME中,它是最重要的.循环的RNA疫苗使用.免疫疗法免疫疗法

更多相关视频

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...